Review: taking Hytrin and Cialis together


Summary

Drug interactions are reported among people who take Hytrin and Cialis together. This review analyzes the effectiveness and drug interactions between Hytrin and Cialis. It is created by eHealthMe based on reports of 72 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Hytrin and Cialis >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Hytrin

Hytrin has active ingredients of terazosin hydrochloride. It is often used in high blood pressure. (latest outcomes from Hytrin 6,187 users)

Cialis

Cialis has active ingredients of tadalafil. It is often used in erection problems. (latest outcomes from Cialis 9,093 users)

On Jul, 25, 2016

72 people who take Hytrin, Cialis are studied.


Number of reports submitted per year:

Hytrin and Cialis drug interactions.

Drug effectiveness over time:

Hytrin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 40.0% - (2 of 5 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 100.0% - (1 of 1 people)
Cialis:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 40.0% - (2 of 5 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 75.0% - (3 of 4 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Hytrin:
  • female: 0.0% - (0 of 0 people)
  • male: 38.0% - (5 of 13 people)
Cialis:
  • female: 0.0% - (0 of 0 people)
  • male: 61.0% - (8 of 13 people)

Drug effectiveness by age:

Hytrin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 40.0% - (4 of 10 people)
Cialis:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 60.0% - (6 of 10 people)

Most common drug interactions over time *:

< 1 month:
  • dysuria
1 - 6 months:
  • indigestion
  • urinary hesitation
  • urine flow decreased
  • urticaria
1 - 2 years:
  • blood pressure increased
  • vision blurred
  • visual acuity reduced
2 - 5 years:
  • blood pressure increased
  • vision blurred
  • visual acuity reduced
  • lack of coordination
  • loose stools
  • neuropathy peripheral
5 - 10 years:
  • indigestion
  • lack of coordination
  • neuropathy peripheral
10+ years:
  • loose stools
not specified:
  • drug ineffective
  • therapeutic response decreased
  • headache
  • vision blurred
  • cyanopsia
  • diabetic neuropathy
  • hypoxia
  • lung infiltration
  • coronary artery disease
  • dysuria

Most common drug interactions by gender *:

male:
  • drug ineffective
  • therapeutic response decreased
  • headache
  • vision blurred
  • cyanopsia
  • diabetic neuropathy
  • dysuria
  • hypoxia
  • lung infiltration
  • visual acuity reduced

Most common drug interactions by age *:

40-49:
  • accidental exposure
  • diabetic neuropathy
  • dysuria
  • epicondylitis
  • erection increased
  • groin pain
  • iliac artery occlusion
  • neurogenic bladder
  • organic erectile dysfunction
  • painful erection
50-59:
  • muscle rupture
  • coronary artery disease
  • myocardial infarction
  • back pain
  • insomnia
  • muscle spasms
  • musculoskeletal stiffness
  • pain
  • renal pain
  • therapeutic response decreased
60+:
  • drug ineffective
  • headache
  • therapeutic response decreased
  • vision blurred
  • cyanopsia
  • hypoxia
  • lung infiltration
  • blindness transient
  • blood pressure decreased
  • diabetes mellitus

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Hytrin and Cialis?

Can you answer these questions?

More questions for: Hytrin, Cialis

You may be interested in these reviews

More reviews for: Hytrin, Cialis

On eHealthMe, Hytrin (terazosin hydrochloride) is often used to treat high blood pressure. Cialis (tadalafil) is often used to treat erection problems. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.